other material
confidence high
sentiment positive
materiality 0.60
Ensysce completes $7M offering, believes it meets Nasdaq equity requirement
Ensysce Biosciences, Inc.
- Raised ~$7M gross via public offering of common stock and warrants on May 12, 2023.
- Previously notified of non-compliance with Nasdaq's $2.5M stockholders' equity minimum.
- Hearings Panel granted extension to June 12, 2023; company now believes it satisfies the Rule.
- Awaiting formal Nasdaq confirmation of compliance status.